These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35820417)

  • 41. High throughput platform technology for rapid target identification in personalized phage therapy.
    Bayat F; Hilal A; Thirugnanasampanthar M; Tremblay D; Filipe CDM; Moineau S; Didar TF; Hosseinidoust Z
    Nat Commun; 2024 Jul; 15(1):5626. PubMed ID: 38992046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Spatial Heterogeneity of the Gut Limits Predation and Fosters Coexistence of Bacteria and Bacteriophages.
    Lourenço M; Chaffringeon L; Lamy-Besnier Q; Pédron T; Campagne P; Eberl C; Bérard M; Stecher B; Debarbieux L; De Sordi L
    Cell Host Microbe; 2020 Sep; 28(3):390-401.e5. PubMed ID: 32615090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
    Ngiam L; Schembri MA; Weynberg K; Guo J
    Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteriophages of the Urinary Microbiome.
    Miller-Ensminger T; Garretto A; Brenner J; Thomas-White K; Zambom A; Wolfe AJ; Putonti C
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29378882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Bacteriophages to Target Intracellular Pathogens.
    Fajardo-Lubian A; Venturini C
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S423-S432. PubMed ID: 37932114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phage Proteins Required for Tail Fiber Assembly Also Bind Specifically to the Surface of Host Bacterial Strains.
    North OI; Davidson AR
    J Bacteriol; 2021 Jan; 203(3):. PubMed ID: 33139482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
    Vinodkumar CS; Neelagund YF; Kalsurmath S
    J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system dependent inhibition of bystander bacteria.
    Chatterjee A; Willett JLE; Dunny GM; Duerkop BA
    PLoS Genet; 2021 Jan; 17(1):e1009204. PubMed ID: 33411815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of novel phages for control of multi-drug resistant Escherichia coli O177 on artificially contaminated beef and their potential to disrupt biofilm formation.
    Montso PK; Mlambo V; Ateba CN
    Food Microbiol; 2021 Apr; 94():103647. PubMed ID: 33279072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and Genomic Analysis of a Novel Drexlervirial Bacteriophage IME268 with Lytic Activity Against
    Nazir A; Qi C; Shi N; Gao X; Feng Q; Qing H; Li F; Tong Y
    Infect Drug Resist; 2022; 15():1533-1546. PubMed ID: 35414748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteriophages: Status quo and emerging trends toward one health approach.
    Samson R; Dharne M; Khairnar K
    Sci Total Environ; 2024 Jan; 908():168461. PubMed ID: 37967634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
    PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of bacteriophages against saprophytic mesophilic bacteria in minimally processed food.
    Wójcicki M; Żuwalski A; Świder O; Gientka I; Shymialevich D; Błażejak S
    Acta Sci Pol Technol Aliment; 2021; 20(4):473-484. PubMed ID: 34724371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.
    Matsuzaki S; Rashel M; Uchiyama J; Sakurai S; Ujihara T; Kuroda M; Ikeuchi M; Tani T; Fujieda M; Wakiguchi H; Imai S
    J Infect Chemother; 2005 Oct; 11(5):211-9. PubMed ID: 16258815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.